32 related articles for article (PubMed ID: 10609502)
1. Generalized low levels of serum N-glycans associate with better health status.
Fan J; Sha J; Chang S; Zhao H; Niu X; Gu Y; Gu J; Ren S
Aging Cell; 2023 Jul; 22(7):e13855. PubMed ID: 37132100
[TBL] [Abstract][Full Text] [Related]
2. Desialylation of Atg5 by sialidase (Neu2) enhances autophagosome formation to induce anchorage-dependent cell death in ovarian cancer cells.
Satyavarapu EM; Nath S; Mandal C
Cell Death Discov; 2021 Feb; 7(1):26. PubMed ID: 33526785
[TBL] [Abstract][Full Text] [Related]
3. Association between Metabolites and the Risk of Lung Cancer: A Systematic Literature Review and Meta-Analysis of Observational Studies.
Lee KB; Ang L; Yau WP; Seow WJ
Metabolites; 2020 Sep; 10(9):. PubMed ID: 32899527
[TBL] [Abstract][Full Text] [Related]
4. Deep Metabolomics of a High-Grade Serous Ovarian Cancer Triple-Knockout Mouse Model.
Huang D; Gaul DA; Nan H; Kim J; Fernández FM
J Proteome Res; 2019 Aug; 18(8):3184-3194. PubMed ID: 31290664
[TBL] [Abstract][Full Text] [Related]
5. Sialic Acid-Targeted Biointerface Materials and Bio-Applications.
Xiong Y; Li M; Lu Q; Qing G; Sun T
Polymers (Basel); 2017 Jun; 9(7):. PubMed ID: 30970926
[TBL] [Abstract][Full Text] [Related]
6. Serum sialylation changes in cancer.
Zhang Z; Wuhrer M; Holst S
Glycoconj J; 2018 Apr; 35(2):139-160. PubMed ID: 29680984
[TBL] [Abstract][Full Text] [Related]
7. Sialic acids: biomarkers in endocrinal cancers.
Ghosh S
Glycoconj J; 2015 May; 32(3-4):79-85. PubMed ID: 25777812
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for substrate specificity of mammalian neuraminidases.
Smutova V; Albohy A; Pan X; Korchagina E; Miyagi T; Bovin N; Cairo CW; Pshezhetsky AV
PLoS One; 2014; 9(9):e106320. PubMed ID: 25222608
[TBL] [Abstract][Full Text] [Related]
9. Serum glycoconjugates and ceruloplasmin in cancer of uterine cervix.
Upadhya S; Upadhya S; Prabhu KS
Indian J Clin Biochem; 2002 Jan; 17(1):20-4. PubMed ID: 23105331
[TBL] [Abstract][Full Text] [Related]
10. Investigation of ovarian cancer associated sialylation changes in N-linked glycopeptides by quantitative proteomics.
Shetty V; Hafner J; Shah P; Nickens Z; Philip R
Clin Proteomics; 2012 Aug; 9(1):10. PubMed ID: 22856521
[TBL] [Abstract][Full Text] [Related]
11. Where catabolism meets signalling: neuraminidase 1 as a modulator of cell receptors.
Pshezhetsky AV; Hinek A
Glycoconj J; 2011 Oct; 28(7):441-52. PubMed ID: 21928149
[TBL] [Abstract][Full Text] [Related]
12. Tissue and serum alpha 2-3- and alpha 2-6-linkage specific sialylation changes in oral carcinogenesis.
Shah MH; Telang SD; Shah PM; Patel PS
Glycoconj J; 2008 Apr; 25(3):279-90. PubMed ID: 18158621
[TBL] [Abstract][Full Text] [Related]
13. Combined detection of sialic acid and hydroxyproline in diagnosis of ovarian cancer and its comparison with human epididymis protein 4 and carbohydrate antigen 125.
Li PL; Zhang X; Li TF; Wang LL; Du LT; Yang YM; Li J; Wang HY; Zhang Y; Wang CX
Clin Chim Acta; 2015 Jan; 439():148-53. PubMed ID: 25445414
[TBL] [Abstract][Full Text] [Related]
14. Preoperative determination of several serum tumor markers in patients with primary epithelial ovarian carcinoma.
Kudoh K; Kikuchi Y; Kita T; Tode T; Takano M; Hirata J; Mano Y; Yamamoto K; Nagata I
Gynecol Obstet Invest; 1999; 47(1):52-7. PubMed ID: 9852392
[TBL] [Abstract][Full Text] [Related]
15. The diagnostic value of determination of serum GOLPH3 associated with CA125, CA19.9 in patients with ovarian cancer.
Fan HY; Duan DM; Liu YF
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4039-4044. PubMed ID: 29028099
[TBL] [Abstract][Full Text] [Related]
16. New tumor markers: CA125 and beyond.
Bast RC; Badgwell D; Lu Z; Marquez R; Rosen D; Liu J; Baggerly KA; Atkinson EN; Skates S; Zhang Z; Lokshin A; Menon U; Jacobs I; Lu K
Int J Gynecol Cancer; 2005; 15 Suppl 3():274-81. PubMed ID: 16343244
[TBL] [Abstract][Full Text] [Related]
17. Alternatives to risk-reducing surgery for ovarian cancer.
Gadducci A; Sergiampietri C; Tana R
Ann Oncol; 2013 Nov; 24 Suppl 8():viii47-viii53. PubMed ID: 24131970
[TBL] [Abstract][Full Text] [Related]
18. Total serum sialic acid concentration as a supporting marker of malignancy in ovarian neoplasia.
Berbeć H; Paszkowska A; Siwek B; Gradziel K; Cybulski M
Eur J Gynaecol Oncol; 1999; 20(5-6):389-92. PubMed ID: 10609502
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
